Suven Pharma Soars 12% After Cohance Lifesciences Merger
Introduction In a bold strategic move, Suven Pharma has announced its merger with Cohance Lifesciences , as a result of which Suven Pharma soars Net Profit by 12%. This joining…
Suven Pharma: 10% in Q3 Due to Margin Erosion
Introduction In the ever-evolving landscape of the pharmaceutical industry, Suven Pharma has stood as a stalwart, navigating through challenges with resilience and foresight. With recent erosion have led to a…
